Published in
Taylor and Francis Group, OncoImmunology, 1(3), p. e27219
DOI: 10.4161/onci.27219
Links
- ORCID
- Taylor and Francis Group | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy
Journal article published in 2014 by
Florian Wimmers 
,
Erik Hjg Aarntzen,
Gerty Schreibelt,
Joannes Fm Jacobs,
Cornelis Ja Punt,
Cornelis Ja Punt,
I. Jolanda M. de Vries,
Carl G. Figdor,
I. Jolanda M. de Vries
,
Erik Hjg Aarntzen,
Gerty Schreibelt,
Joannes Fm Jacobs,
Cornelis Ja Punt,
Cornelis Ja Punt,
I. Jolanda M. de Vries,
Carl G. Figdor,
I. Jolanda M. de Vries
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Bioassays that predict clinical outcome are essential to optimize cellular anticancer immunotherapy. We have recently developed a robust and simple skin test to evaluate the capacity of tumor-specific T cells to migrate, recognize their targets and exert effector functions. This bioassay detects T cells with an elevated antineoplastic potential and hence rapidly identifies patients responding to immunotherapy.